TNF and acquired idiopathic inflammatory myopathy: Similarly, early administration of infliximab in DM patients with acute interstitial pneumonia demonstrated favourable outcomes, indicating the potential therapeutic value of TNF‐α inhibitors in the treatment of IIM‐associated ILD.